Intestinal failure (IF) is a well identified clinical condition, which is characterised by the
reduction of functional gut capacity below the minimum needed for adequate digestion and …

N-3 lipids exhibit strong immunologic properties. They offer the possibility to counterbalance
the negative effects of conventional n-6 fatty acids. Recent studies exhibit positive effects of …

Objective: Supplementation of clinical nutrition with omega-3 fatty acid in fish oil exerts
immune-modulating and organ-protective effects, even after short-term application. The aim …

Infusion of fish oil-based (n-3) lipids may influence leukocyte function and plasma lipids in
critical care patients. Twenty-one patients with sepsis requiring parenteral nutrition were …

Epidemiologic studies have indicated that high intake of saturated fat and/or animal fat
increases the risk of colon and breast cancer. Omega‐3 PUFAs in fish oil (FO) can inhibit the …

AIM: To investigate the effect of omega-3 fatty acid parenteral supplementation
postoperatively on clinical outcomes and immunomodulation in colorectal cancer patients …

Intestinal failure is defined as a critical reduction of the gut mass or function, below the
minimum needed to absorb nutrients and fluids. The ultimate goal in intestinal failure is to …

Objective: Intestinal ischemia decreases barrier function of the gut and enhances
translocation of bacteria and toxins. Several studies indicate that fish oil can modulate …

Introduction Although the prognostic value of persistent hyperlactatemia in septic shock is
unequivocal, its physiological determinants are controversial. Particularly, the role of …

For years, intravenous lipid supply has been considered as a means of providing an efficient
fuel to many tissues of the body and of preventing or correcting essential fatty acid …